Pharma-Bio Serv (OTCMKTS:PBSV) Posts Quarterly Earnings Results, Beats Estimates By $0.35 EPS

Pharma-Bio Serv (OTCMKTS:PBSV) posted its earnings results on Monday. The company reported $0.37 earnings per share for the quarter, beating the consensus estimate of $0.02 by $0.35, reports. The business had revenue of $2.47 million for the quarter, compared to analyst estimates of $2.70 million. Pharma-Bio Serv had a negative net margin of 8.18% and a negative return on equity of 5.61%.

Pharma-Bio Serv Price Performance

Shares of PBSV stock opened at $0.43 on Wednesday. Pharma-Bio Serv has a 12 month low of $0.31 and a 12 month high of $0.90. The firm has a market capitalization of $9.86 million, a P/E ratio of -14.33 and a beta of 0.53. The company’s fifty day moving average price is $0.55 and its two-hundred day moving average price is $0.57.

Pharma-Bio Serv Announces Dividend

The firm also recently announced a dividend, which will be paid on Thursday, March 20th. Investors of record on Friday, February 28th will be issued a dividend of $0.075 per share. The ex-dividend date of this dividend is Friday, February 28th. Pharma-Bio Serv’s payout ratio is -250.00%.

About Pharma-Bio Serv

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.